User profiles for Michael S. Glickman

Michael S Glickman

Member, Immunology Program, Memorial Sloan Kettering Cancer Center
Verified email at MSKCC.org
Cited by 10913

[HTML][HTML] Determinants of COVID-19 disease severity in patients with cancer

…, Y Bogler, M Caldararo, CJ Figueroa, MS Glickman… - Nature medicine, 2020 - nature.com
As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with cancer comprised …

[PDF][PDF] A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis

MS Glickman, JS Cox, WR Jacobs - Molecular cell, 2000 - cell.com
Colonial morphology of pathogenic bacteria is often associated with virulence. For M.
tuberculosis, the causative agent of tuberculosis (TB), virulence is correlated with the formation of …

TOX is a critical regulator of tumour-specific T cell differentiation

…, Y Liu, NK Altorki, P Lauer, O Levy, MS Glickman… - Nature, 2019 - nature.com
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the
functional effector or memory T cell states 1 , 2 , 3 , 4 , 5 – 6 . Here we identify the nuclear factor …

The mechanism of action of BCG therapy for bladder cancer—a current perspective

G Redelman-Sidi, MS Glickman, BH Bochner - Nature reviews urology, 2014 - nature.com
Bacillus Calmette–Guérin (BCG) has been used to treat non-muscle-invasive bladder
cancer for more than 30 years. It is one of the most successful biotherapies for cancer in use. …

[HTML][HTML] Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline

MS Glickman, WR Jacobs - Cell, 2001 - cell.com
“If we ask further what significance belongs to the results gained in this study of tuberculosis
it must be considered a gain for science that it has been possible for the first time to …

Bacterial DNA repair by non-homologous end joining

S Shuman, MS Glickman - Nature Reviews Microbiology, 2007 - nature.com
The capacity to rectify DNA double-strand breaks (DSBs) is crucial for the survival of all
species. DSBs can be repaired either by homologous recombination (HR) or non-homologous …

Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule

…, N Fujiwara, SA Porcelli, MS Glickman - The Journal of …, 2005 - rupress.org
… Porcelli, Michael S. Glickman; Mycobacterium tuberculosis controls host innate immune
activation through cyclopropane modification of a glycolipid effector molecule . J Exp Med 21 …

[HTML][HTML] A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo

…, M Samstein, X Su, EG Pamer, MS Glickman - PLoS …, 2011 - journals.plos.org
CD4 T cell deficiency or defective IFNγ signaling render humans and mice highly susceptible
to Mycobacterium tuberculosis (Mtb) infection. The prevailing model is that Th1 CD4 T cells …

[HTML][HTML] CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence

…, L Chu, A Hochschild, BE Nickels, MS Glickman - Cell, 2009 - cell.com
Mycobacterium tuberculosis is arguably the world's most successful infectious agent because
of its ability to control its own cell growth within the host. Bacterial growth rate is closely …

Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C

…, H Zhu, S Shuman, MS Glickman - Nature structural & …, 2005 - nature.com
DNA double-strand breaks (DSBs) can be repaired either via homologous recombination (HR)
or nonhomologous end-joining (NHEJ). Both pathways are operative in eukaryotes, but …